MOH — authorised 13 March 2007
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
MOH authorised Tykerb on 13 March 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 13 March 2007.
NOVARTIS PHARMS CORP holds the UAE marketing authorisation.